STOCK TITAN

Director at Cleveland-Cliffs (NYSE: CLF) gets 15,334-share award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CRONIN JANE M. reported acquisition or exercise transactions in this Form 4 filing.

CLEVELAND-CLIFFS INC. director Jane M. Cronin received an equity compensation grant of 15,334 Common Shares on 2026-04-21 at no cash cost per share. The award consists of restricted shares designated as the 2026 Director Restricted Shares under the 2021 Nonemployee Directors' Compensation Plan, bringing her direct holdings to 74,110 Common Shares.

Positive

  • None.

Negative

  • None.
Insider CRONIN JANE M.
Role null
Type Security Shares Price Value
Grant/Award Common Shares 15,334 $0.00 --
Holdings After Transaction: Common Shares — 74,110 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted share grant 15,334 shares 2026 Director Restricted Shares granted on 2026-04-21
Grant price per share $0.0000 per share Equity compensation, not an open-market purchase
Total shares after award 74,110 shares Director’s direct holdings following the transaction
restricted shares financial
"Reflects the number of restricted shares granted to the Reporting Person"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
2026 Director Restricted Shares financial
"granted to the Reporting Person as the 2026 Director Restricted Shares"
2021 Nonemployee Directors' Compensation Plan financial
"pursuant to the 2021 Nonemployee Directors' Compensation Plan"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CRONIN JANE M.

(Last)(First)(Middle)
200 PUBLIC SQUARE
SUITE 3300

(Street)
CLEVELAND OHIO 44114

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLEVELAND-CLIFFS INC. [ CLF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares04/21/2026A15,334(1)A$074,110D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects the number of restricted shares granted to the Reporting Person as the 2026 Director Restricted Shares pursuant to the 2021 Nonemployee Directors' Compensation Plan.
Remarks:
/s/ James D. Graham by Power of Attorney04/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Cleveland-Cliffs (CLF) director Jane M. Cronin report on this Form 4?

Jane M. Cronin reported receiving a grant of 15,334 Cleveland-Cliffs Common Shares as restricted stock. The award was issued at no cash cost per share as director compensation, increasing her direct ownership stake to a total of 74,110 Common Shares after the transaction.

How many Cleveland-Cliffs (CLF) shares did the director receive in this award?

The director received 15,334 Common Shares of Cleveland-Cliffs. These shares are restricted stock granted as the 2026 Director Restricted Shares under the company’s 2021 Nonemployee Directors' Compensation Plan and represent additional compensation rather than an open-market purchase of stock.

What is the price per share for the Cleveland-Cliffs (CLF) restricted stock grant?

The restricted stock grant was reported at a price of $0.0000 per share. This reflects that the 15,334 Common Shares were awarded as equity compensation, not purchased for cash, under Cleveland-Cliffs’ 2021 Nonemployee Directors' Compensation Plan for nonemployee directors.

What are Jane M. Cronin’s total Cleveland-Cliffs (CLF) holdings after this Form 4 transaction?

Following the restricted stock award, Jane M. Cronin directly holds 74,110 Common Shares of Cleveland-Cliffs. This total includes the newly granted 15,334 restricted shares and represents her direct ownership position as disclosed in the latest insider transaction filing.

Under which plan were the Cleveland-Cliffs (CLF) restricted shares granted to the director?

The restricted shares were granted under Cleveland-Cliffs’ 2021 Nonemployee Directors' Compensation Plan. The filing notes they represent the 2026 Director Restricted Shares, indicating a scheduled equity award program used to compensate nonemployee members of the board of directors in stock.